Showing results (81-90 of 92) with videos related to
Sort By:
Pageof 10
Lung Cancer (Amsterdam, Netherlands)|November 22, 2021
A phase I/II study of osimertinib in EGFR exon 20 insertion mutation-positive non-small cell lung cancerHiroyuki Yasuda, Eiki Ichihara, Jun Sakakibara-Konishi, et al.Clinical Pharmacology and Therapeutics|June 18, 2024
Multicenter Pharmacokinetic and Pharmacodynamic Study of Pembrolizumab for Non-small-Cell Lung Cancer in Patients Aged 75 Years and OlderShigehiro Yagishita, Yuta Yamanaka, Takayasu Kurata, et al.Internal Medicine (Tokyo, Japan)|April 17, 2024
Acute Onset of Constrictive Pericarditis Due to Acute Myelomonocytic Leukemia: A Case and Literature ReviewNaoki Kosaka, Takanori Uchiyama, Masahiro Onozawa, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2022
A Large-Scale Prospective Concordance Study of Plasma- and Tissue-Based Next-Generation Targeted Sequencing for Advanced Non-Small Cell Lung Cancer (LC-SCRUM-Liquid)Akira Sugimoto, Shingo Matsumoto, Hibiki Udagawa, et al.Oncotarget|January 7, 2017
Expression of Notch1 and Numb in small cell lung cancerHajime Kikuchi, Jun Sakakibara-Konishi, Megumi Furuta, et al.Journal of Gastroenterology and Hepatology|March 19, 2020
Prevalence, clinical course, and predictive factors of immune checkpoint inhibitor monotherapy-associated hepatitis in JapanTakashi Kitagataya, Goki Suda, Kazunori Nagashima, et al.Respiratory Research|June 29, 2022
Effects of obesity on CC16 and their potential role in overweight/obese asthmaHouman Goudarzi, Hirokazu Kimura, Hiroki Kimura, et al.Translational Lung Cancer Research|October 24, 2025
Long-term follow-up results from the GLORY study: phase II study of gumarontinib in East Asian patients with MET exon 14 skipping mutated non-small cell lung cancerShun Lu, Yongfeng Yu, Jianya Zhou, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 12, 2024
Clinical Significance of a Prospective Large Genomic Screening for SCLC: The Genetic Classification and a Biomarker-Driven Phase 2 Trial of GedatolisibShigeki Umemura, Hibiki Udagawa, Takaya Ikeda, et al.Eclinicalmedicine|April 25, 2023
Gumarontinib in patients with non-small-cell lung cancer harbouring MET exon 14 skipping mutations: a multicentre, single-arm, open-label, phase 1b/2 trialYongfeng Yu, Jianya Zhou, Xingya Li, et al.Pageof 10